28.07.2009 11:00:00

Celanese Corporation Reports Second Quarter Results

Second quarter highlights:

  • Net sales were $1,244 million, down 33% from prior year period
  • Operating profit was $89 million versus $207 million in prior year period
  • Net earnings were $104 million versus $134 million in prior year period
  • Operating EBITDA was $243 million versus $406 million in prior year period
  • Diluted EPS from continuing operations was $0.67 versus $1.21 in prior year period
  • Adjusted EPS was $0.53 versus $1.20 in prior year period
   
Three Months Ended Six Months Ended
  June 30, June 30,
(in $ millions, except per share data) 2009   2008 2009   2008
Net sales 1,244 1,868 2,390 3,714
Operating profit (loss) 89 207 116 441
Net earnings (loss) attributable to Celanese Corporation 104 134 84 279
Operating EBITDA 1 243 406 379 787
Diluted EPS - continuing operations $ 0.67 $ 1.21 $ 0.54 $ 2.08
Diluted EPS - total $ 0.66 $ 0.80 $ 0.54 $ 1.67
Adjusted EPS 2 $ 0.53 $ 1.20 $ 0.62 $ 2.26

1 Non-U.S. GAAP measure. See reconciliation in table 1.

2 Non-U.S. GAAP measure. See reconciliation in table 6.

Celanese Corporation (NYSE: CE), a leading, global chemical company, today reported second quarter 2009 net sales of $1,244 million, a 33 percent decrease from the same period last year, primarily driven by lower pricing and lower volumes on weak global demand. Operating profit was $89 million compared with $207 million in the prior year period as the lower net sales more than offset lower expenses driven by the company’s restructuring initiatives and fixed cost reduction efforts. Net earnings were $104 million compared with $134 million in the same period last year.

Adjusted earnings per share for the second quarter of 2009 were $0.53 compared with $1.20 in the prior year period. The effective tax rate and diluted share count used in adjusted earnings per share in the current period were 29 percent and 157 million, respectively. Operating EBITDA in the period was $243 million compared with $406 million in the prior year period. Both adjusted earnings per share and operating EBITDA excluded a net $3 million benefit of other charges and other adjustments, primarily related to a $19 million tax benefit associated with one of the company’s Advanced Engineered Materials equity affiliates.

"Our businesses delivered results consistent with our expectations while executing on strategies that better position Celanese during this ongoing global recession and the future recovery,” said David Weidman, chairman and chief executive officer. "While the current economic environment continues to be challenging, growth in Asia continued while demand in North America and in many European segments stabilized during the quarter. Operating margins improved from the first quarter of 2009, and while our volumes also increased sequentially, global end-consumer demand remained weak.”

Recent Highlights

  • Received American Chemistry Council’s (ACC) Responsible Care® Sustained Excellence Award for mid-size companies. The annual award, the most prestigious award given under ACC’s Responsible Care initiative, recognized companies for outstanding leadership under ACC’s Environmental Health and Safety performance criteria.
  • Completed the sale of its polyvinyl alcohol (PVOH) business to Sekisui Chemical Co., Ltd. for the purchase price of approximately $173 million, excluding the value of accounts receivable and payable retained by Celanese.
  • Reached agreement on a Project of Closure for its acetic acid and vinyl acetate monomer production operations at its Pardies, France, site. These operations are expected to cease by December 2009.
  • Amended its $650 million revolving credit facility. The amendment lowered the total revolver commitment to $600 million and increased the first lien senior secured leverage ratio for a period of six quarters, beginning June 30, 2009, and ending December 31, 2010.
  • Highlighted recent breakthroughs with the announcement of its new and proprietary AOPlus®2 acetic acid technology, which allows for expansion up to 1.5 million tons per reactor. Also announced plans to double the current capacity of its Nanjing, China acetic acid facility from 600,000 tons to 1.2 million tons by the end of 2009.

Second Quarter Segment Overview

Consumer Specialties

Consumer Specialties continued to deliver strong performance as higher pricing and Acetate Products venture growth in China, as well as lower overall costs, offset modest volume declines resulting from softer product demand. Net sales in the second quarter of 2009 were $280 million compared with $292 million in the prior year period. Higher pricing could not offset the lower volumes, primarily in North America and Europe, and negative currency impacts. Operating profit was $66 million compared with $46 million in the same period last year, as higher pricing, lower raw material and energy costs, and benefits from the company’s fixed cost reduction efforts more than offset the impact of the lower volumes. Operating EBITDA was $134 million compared with $107 million in the same period last year. Cost affiliate dividends, primarily from the company’s acetate China ventures, were $53 million, $7 million higher than the prior year period.

Advanced Engineered Materials

Advanced Engineered Materials experienced sequential volume improvements and benefited from its fixed cost reduction efforts during the second quarter of 2009, while significantly lower volumes in many of its end-use industries continued to impact year-over-year performance. Net sales in the quarter were $184 million compared with $300 million in the prior year period, primarily driven by lower volumes in the U.S. and European automotive markets, as well as other consumer and durable goods segments. However, volumes increased sequentially in all regions and across many end-market segments as customer inventory destocking significantly diminished during the quarter. Operating profit was $0 compared with $37 million in the same period last year. Lower raw material and energy costs, coupled with fixed cost reductions, could not offset the lower volumes. Year-over-year, the business improved variable margins and aggressively managed its production and inventory levels in response to lower product demand. Operating EBITDA was $28 million compared with $68 million in the same period last year and increased significantly from the first quarter of 2009. Excluding the equity affiliate tax benefit of $19 million, Advanced Engineered Materials’ strategic affiliates contributed $4 million of earnings, $6 million lower than the prior year period, driven by similar economic factors.

Industrial Specialties

Industrial Specialties delivered sustained earnings sequentially and year-over-year while it continued to realize the benefits of its expansions in Asia. Net sales were $267 million compared with $386 million in the prior year period, primarily due to lower volumes associated with softer demand for polyvinyl alcohol (PVOH) and the impact of the company’s AT Plastics force majeure. The decrease in net sales was also attributed to lower pricing and the negative impacts of currency. Volumes increased sequentially on improved demand in North America, Europe and Asia, particularly in the company’s emulsions business. Operating profit was $19 million compared with $20 million in the same period last year, as lower raw material and energy costs, and benefits from the company’s fixed cost reduction efforts, partially offset the impact of lower volumes and pricing. Operating EBITDA was $35 million, $2 million lower than the prior year period. Second quarter 2009 results included the performance of the company’s PVOH business, which was divested on July 1, 2009.

Acetyl Intermediates

Acetyl Intermediates continued to leverage its technology and cost leadership position during the quarter. Net sales were $622 million in the second quarter of 2009 compared with $1,067 million in the same period last year, primarily due to lower pricing and modestly lower volumes. Lower year-over-year industry utilization rates caused by reduced global demand, coupled with lower raw material costs, drove the pricing decline. The company’s operating rates for its acetic acid facilities remained at high levels during the second quarter of 2009, however, volumes in vinyl acetate monomer and other derivative products were lower, reflecting the reduced demand. Industry demand in Asia has continued to increase sequentially from its lowest levels in the fourth quarter of 2008. Demand in Europe and the Americas remained weaker in comparison, but has also shown modest improvement during the same period. Operating profit was $40 million compared with $148 million in the same period last year as lower raw material and energy costs, as well as benefits from the company’s fixed spending reduction efforts, could not offset the lower revenue. Operating EBITDA was $76 million compared with $227 million in the same period last year. Dividends from the company’s cost investments, including its Ibn Sina cost affiliate, were $3 million compared with $29 million in the prior year period, due to significantly lower global pricing for methanol and methyl tertiary-butyl ether (MTBE).

Taxes

The tax rate for adjusted earnings per share was 29 percent in the first six months of 2009 compared with 26 percent in the first six months of 2008. The U.S. GAAP effective tax rate for continuing operations for the second quarter of 2009 was 14 percent versus 18 percent in the second quarter of 2008. The decrease in the effective income tax rate is primarily due to a decrease in additions to reserves for uncertain tax positions and related interest, offset by an increase in valuation allowances on certain foreign net deferred tax assets and lower earnings in jurisdictions participating in tax holidays. The company had a net cash tax refund of less than $1 million in the first six months of 2009 compared with $44 million of cash taxes paid in the first six months of 2008. The decrease in cash taxes paid is primarily due to German tax refunds and the timing of cash taxes in certain jurisdictions.

Equity and Cost Investments

Earnings from equity investments and dividends from cost investments, which are reflected in the company’s adjusted earnings and operating EBITDA, were $64 million compared with $92 million in the prior year period. The 2009 adjusted results excluded a $19 million tax benefit related to one of the company’s Advanced Engineered Materials equity affiliates. Higher dividends from the company’s acetate China ventures were offset by lower dividends from the company’s Ibn Sina cost affiliate and lower equity earnings from the Advanced Engineered Materials equity affiliates. Equity and cost investment dividends, which are included in cash flows, were $67 million, a $20 million decrease from the same period last year, primarily due to lower dividends from the Ibn Sina cost affiliate.

Cash Flow

Cash and cash equivalents at the end of the second quarter of 2009 were $1,145 million compared with $983 million at the end of the second quarter of 2008. During the first six months of 2009, the company generated $299 million in cash from operating activities compared with $346 million in the same period last year. Lower cash taxes and lower capital expenditures helped to offset reduced earnings in the period.

"Celanese continued its strong cash performance in the quarter,” said Steven Sterin, senior vice president and chief financial officer. "Our fiscal discipline and immediate benefits from our restructuring efforts have enabled us to further enhance our strategic and operational flexibility.”

During the second quarter of 2009, the company generated approximately $137 million in adjusted free cash flow, excluding approximately $75 million in value added tax payments related to the relocation of Ticona’s business in Kelsterbach, Germany. The company invested $89 million of capital expenditures related to the Kelsterbach relocation, which is reflected in investing activities.

Outlook

"We expect the economic environment to remain challenging during the second half of 2009. We also see sustained demand across our key segments and geographies,” said Weidman. "We are pleased with the significant and sustainable improvements we continue to make to our cost basis and capital structure. Additionally, our earnings power expansion initiatives and leverage to a global economic recovery, which we outlined at our Investor Day in May, should continue to enhance our strategic, competitive position and drive shareholder value throughout the economic recovery.”

As a global leader in the chemicals industry, Celanese Corporation makes products essential to everyday living. Our products, found in consumer and industrial applications, are manufactured in North America, Europe and Asia. Net sales totaled $6.8 billion in 2008, with approximately 65% generated outside of North America. Known for operational excellence and execution of its business strategies, Celanese delivers value to customers around the globe with innovations and best-in-class technologies. Based in Dallas, Texas, the company employs approximately 8,000 employees worldwide. For more information on Celanese Corporation, please visit the company's website at www.celanese.com.

Forward-Looking Statements

This release may contain "forward-looking statements,” which include information concerning the company’s plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. When used in this release, the words "outlook,” "forecast,” "estimates,” "expects,” "anticipates,” "projects,” "plans,” "intends,” "believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the company’s control, could cause actual results to differ materially from those expressed as forward-looking statements. Certain of these risk factors are discussed in the company’s filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.

Reconciliation of Non-U.S. GAAP Measures to U.S. GAAP

This release reflects five performance measures, operating EBITDA, affiliate EBITDA, adjusted earnings per share, net debt and adjusted free cash flow, as non-U.S. GAAP measures. The most directly comparable financial measure presented in accordance with U.S. GAAP in our consolidated financial statements for operating EBITDA is operating profit; for affiliate EBITDA is equity in net earnings of affiliates; for adjusted earnings per share is earnings per common share-diluted; for net debt is total debt; and for adjusted free cash flow is cash flow from operations.

Use of Non-U.S. GAAP Financial Information

  • Operating EBITDA, a measure used by management to measure performance, is defined as operating profit from continuing operations, plus equity in net earnings from affiliates, other income and depreciation and amortization, and further adjusted for other charges and adjustments. We may provide guidance on operating EBITDA and are unable to reconcile forecasted operating EBITDA to a GAAP financial measure because a forecast of Other Charges and Adjustments is not practical. Our management believes operating EBITDA is useful to investors because it is one of the primary measures our management uses for its planning and budgeting processes and to monitor and evaluate financial and operating results. Operating EBITDA is not a recognized term under U.S. GAAP and does not purport to be an alternative to operating profit as a measure of operating performance or to cash flows from operating activities as a measure of liquidity. Because not all companies use identical calculations, this presentation of operating EBITDA may not be comparable to other similarly titled measures of other companies. Additionally, operating EBITDA is not intended to be a measure of free cash flow for management’s discretionary use, as it does not consider certain cash requirements such as interest payments, tax payments and debt service requirements nor does it represent the amount used in our debt covenants.
  • Affiliate EBITDA, a measure used by management to measure performance of its equity investments, is defined as the proportional operating profit plus the proportional depreciation and amortization of its equity investments. Affiliate EBITDA, including Celanese Proportional Share of affiliate information on Table 8, is not a recognized term under U.S. GAAP and is not meant to be an alternative to operating cash flow of the equity investments. The company has determined that it does not have sufficient ownership for operating control of these investments to consider their results on a consolidated basis. The company believes that investors should consider affiliate EBITDA when determining the equity investments’ overall value in the company.
  • Adjusted earnings per share is a measure used by management to measure performance. It is defined as net earnings (loss) available to common shareholders plus preferred dividends, adjusted for other charges and adjustments, and divided by the number of basic common shares, diluted preferred shares, and options valued using the treasury method. We may provide guidance on an adjusted earnings per share basis and are unable to reconcile forecasted adjusted earnings per share to a GAAP financial measure without unreasonable effort because a forecast of Other Items is not practical. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding various financial and business trends relating to our financial condition and results of operations, and that when U.S. GAAP information is viewed in conjunction with non-U.S. GAAP information, investors are provided with a more meaningful understanding of our ongoing operating performance. This non-U.S. GAAP information is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information.
  • The tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year, excluding changes in uncertain tax positions, discrete items and changes in management’s assessments regarding the ability to realize deferred tax assets. We analyze this rate quarterly and adjust if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ significantly from the tax rate used for U.S. GAAP reporting in any given reporting period. It is not practical to reconcile our prospective adjusted tax rate to the actual U.S. GAAP tax rate in any future period.
  • Net debt is defined as total debt less cash and cash equivalents. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding changes to the company’s capital structure. Our management and credit analysts use net debt to evaluate the company's capital structure and assess credit quality. This non-U.S. GAAP information is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information.
  • Adjusted free cash flow is defined as cash flow from operations less capital expenditures, other productive asset purchases, operating cash from discontinued operations and certain other charges and adjustments. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding changes to the company’s cash flow. Our management and credit analysts use adjusted free cash flow to evaluate the company’s liquidity and assess credit quality. This non-U.S. GAAP information is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information.

Results Unaudited

The results presented in this release, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.

 
Preliminary Consolidated Statements of Operations - Unaudited
       
Three Months Ended Six Months Ended
June 30, June 30,
(in $ millions, except per share data) 2009 2008 2009 2008
Net sales 1,244 1,868 2,390 3,714
Cost of sales   (996 )   (1,472 )   (1,942 )   (2,900 )
Gross profit 248 396 448 814
 
Selling, general and administrative expenses (114 ) (138 ) (228 ) (274 )
Amortization of Intangible assets 1 (21 ) (20 ) (38 ) (39 )
Research and development expenses (18 ) (18 ) (38 ) (41 )
Other (charges) gains, net (6 ) (7 ) (27 ) (23 )
Foreign exchange gain (loss), net 1 (3 ) 3 4
Gain (loss) on disposition of businesses and assets, net   (1 )   (3 )   (4 )   -  
Operating profit 89 207 116 441
 
Equity in net earnings (loss) of affiliates 27 17 25 27
Interest expense (54 ) (63 ) (105 ) (130 )
Interest income 2 10 5 19
Dividend income - cost investments 56 75 62 103
Other income (expense), net   2     1     3     5  
Earnings (loss) from continuing operations before tax 122 247 106 465
 
Income tax (provision) benefit   (17 )   (45 )   (22 )   (118 )
Earnings (loss) from continuing operations 105 202 84 347
 
Earnings (loss) from operation of discontinued operations (1 ) (112 ) - (112 )
Income tax (provision) benefit, discontinued operations   -     43     -     43  
Earnings (loss) from discontinued operations (1 ) (69 ) - (69 )
 
Net earnings (loss) 104 133 84 278
Less: Net earnings (loss) attributable to noncontrolling interests   -     (1 )   -     (1 )
Net earnings (loss) attributable to Celanese Corporation   104     134     84     279  
 
Cumulative preferred stock dividend   (2 )   (2 )   (5 )   (5 )
Net earnings (loss) available to common shareholders   102     132     79     274  
 
Amounts attributable to Celanese Corporation
Earnings (loss) per common share - basic
Continuing operations $ 0.72 $ 1.33 $ 0.55 $ 2.26
Discontinued operations   (0.01 )   (0.46 )   -     (0.45 )
Net earnings (loss) - basic $ 0.71   $ 0.87   $ 0.55   $ 1.81  
 
Earnings (loss) per common share - diluted
Continuing operations $ 0.67 $ 1.21 $ 0.54 $ 2.08
Discontinued operations   (0.01 )   (0.41 )   -     (0.41 )
Net earnings (loss) - diluted $ 0.66   $ 0.80   $ 0.54   $ 1.67  
 
Weighted average shares (millions)
Basic 143.5 150.9 143.5 151.4
Diluted   157.1     167.8     156.4     167.6  

1 Customer related intangibles

   
Preliminary Consolidated Balance Sheets - Unaudited
June 30, December 31,
(in $ millions) 2009 2008
ASSETS
Current assets
Cash & cash equivalents 1,145 676
Trade receivables - third party and affiliates, net 702 631
Non-trade receivables 231 274
Inventories 473 577
Deferred income taxes 23 24
Marketable securities, at fair value 6 6
Assets held for sale 135 2
Other assets 63 96
Total current assets 2,778 2,286
 
Investments in affiliates 767 789
Property, plant and equipment, net 2,533 2,470
Deferred income taxes 26 27
Marketable securities, at fair value 76 94
Other assets 327 357
Goodwill 788 779
Intangible assets, net 328 364
Total assets 7,623 7,166
 
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities
Short-term borrowings and current
installments of long-term debt - third party and affiliates 224 233
Trade payables - third party and affiliates 557 523
Other liabilities 529 574
Deferred income taxes 15 15
Income taxes payable 17 24
Total current liabilities 1,342 1,369
 
Long-term debt 3,268 3,300
Deferred income taxes 123 122
Uncertain tax positions 229 218
Benefit obligations 1,159 1,167
Other liabilities 1,254 806
Commitments and contingencies
Shareholders' equity
Preferred stock - -
Common stock - -
Treasury stock, at cost (781) (781)
Additional paid-in capital 501 495
Retained earnings 1,114 1,047
Accumulated other comprehensive income (loss), net (588) (579)
Total Celanese Corporation shareholders' equity 246 182
Noncontrolling interests 2 2
Total shareholders' equity 248 184
Total liabilities and shareholders' equity 7,623 7,166
       
Table 1
 
Segment Data and Reconciliation of Operating Profit (Loss) to Operating EBITDA -
a Non-U.S. GAAP Measure
 
Three Months Ended Six Months Ended
June 30, June 30,
(in $ millions) 2009 2008 2009 2008
Net Sales
Advanced Engineered Materials 184 300 349 594
Consumer Specialties 280 292 546 574
Industrial Specialties 267 386 509 751
Acetyl Intermediates 622 1,067 1,194 2,163
Other Activities 1 1 1 1 1
Intersegment eliminations (110 ) (178 ) (209 ) (369 )
Total 1,244   1,868   2,390   3,714  
 
Operating Profit (Loss)
Advanced Engineered Materials - 37 (19 ) 67
Consumer Specialties 66 46 132 96
Industrial Specialties 19 20 29 37
Acetyl Intermediates 40 148 52 325
Other Activities 1 (36 ) (44 ) (78 ) (84 )
Total 89   207   116   441  
 
Equity Earnings, Cost - Dividend Income and Other Income (Expense)
Advanced Engineered Materials 23 11 15 20
Consumer Specialties 53 48 56 48
Industrial Specialties - - - -
Acetyl Intermediates 4 33 8 62
Other Activities 1 5   1   11   5  
Total 85   93   90   135  
 
Other Charges and Other Adjustments 2
Advanced Engineered Materials (14 ) 1 (4 ) 2
Consumer Specialties 3 - 3 1
Industrial Specialties 5 3 8 8
Acetyl Intermediates 4 12 9 20
Other Activities 1 (1 ) 8   14   15  
Total (3 ) 24   30   46  
 
Depreciation and Amortization Expense
Advanced Engineered Materials 19 19 36 39
Consumer Specialties 12 13 24 27
Industrial Specialties 11 14 24 28
Acetyl Intermediates 28 34 55 66
Other Activities 1 2   2   4   5  
Total 72   82   143   165  
 
Operating EBITDA
Advanced Engineered Materials 28 68 28 128
Consumer Specialties 134 107 215 172
Industrial Specialties 35 37 61 73
Acetyl Intermediates 76 227 124 473
Other Activities 1 (30 ) (33 ) (49 ) (59 )
Total 243   406   379   787  

1 Other Activities primarily includes corporate selling, general and administrative expenses and the results from captive insurance companies.

2 See Table 7.

         
Table 2
 
Factors Affecting Second Quarter 2009 Segment Net Sales Compared to Second Quarter 2008
(in percent) Volume Price Currency Other 1 Total
Advanced Engineered Materials -34 % 0 % -5 % 0 % -39 %
Consumer Specialties -10 % 9 % -3 % 0 % -4 %
Industrial Specialties -14 % -12 % -5 % 0 % -31 %
Acetyl Intermediates -11 % -28 % -3 % 0 % -42 %
Total Company -16 % -17 % -4 % 4 % -33 %
 

Factors Affecting Six Months 2009 Segment Net Sales Compared to Six Months 2008

(in percent) Volume Price Currency Other 1 Total
Advanced Engineered Materials -38 % 2 % -5 % 0 % -41 %
Consumer Specialties -10 % 8 % -3 % 0 % -5 %
Industrial Specialties -20 % -7 % -5 % 0 % -32 %
Acetyl Intermediates -15 % -27 % -3 % 0 % -45 %
Total Company -20 % -16 % -4 % 4 % -36 %

1 Includes the effects of the captive insurance companies and the impact of fluctuations in intersegment eliminations.

   
Table 3
 
Cash Flow Information
Six Months Ended
June 30,
(in $ millions) 2009 2008
Net cash provided by operating activities 299 346
Net cash provided by (used in) investing activities 1 183 (33 )
Net cash used in financing activities (59 ) (183 )
Exchange rate effects on cash 46 28
Cash and cash equivalents at beginning of period 676   825  
Cash and cash equivalents at end of period 1,145   983  

1 2009 includes $412 million of cash received and $147 million of capital expenditures related to the Ticona Kelsterbach plant relocation. 2008 includes $311 million of cash received and $62 million of capital expenditures related to the Ticona Kelsterbach plant relocation.

 
Table 4
 
Cash Dividends Received
  Three Months Ended   Six Months Ended
June 30, June 30,
(in $ millions) 2009   2008 2009   2008
Dividends from equity investments 11 12 29 55
Dividends from cost investments 56 75 62 103
Total 67 87 91 158
 
Table 5
   
Net Debt - Reconciliation of a Non-U.S. GAAP Measure
 
June 30, December 31,
(in $ millions) 2009 2008
Short-term borrowings and current
installments of long-term debt - third party and affiliates 224 233
Long-term debt 3,268 3,300
Total debt 3,492 3,533
Less: Cash and cash equivalents 1,145 676
Net Debt 2,347 2,857
       
Table 6
 
Adjusted Earnings (Loss) Per Share - Reconciliation of a Non-U.S. GAAP Measure
 
Three Months Ended Six Months Ended
June 30, June 30,
(in $ millions, except per share data) 2009 2008 2009 2008
Earnings (loss) from continuing operations before tax 122 247 106 465
Non-GAAP adjustments
Other charges and other adjustments 1 (3 ) 24   30   46  
Adjusted Earnings (loss) from continuing operations before tax 119 271 136 511

Income tax (provision) benefit on adjusted earnings 2

(35 ) (70 ) (39 ) (133 )
Less: Noncontrolling interests -   (1 ) -   (1 )
Adjusted Earnings (loss) from continuing operations 84 202 97 379
Preferred dividends (2 ) (2 ) (5 ) (5 )
Adjusted net earnings (loss) available to common shareholders 82 200 92 374
Add back: Preferred dividends 2   2   5   5  
Adjusted net earnings (loss) for adjusted EPS 84   202   97   379  
 
 
Diluted shares (millions) 3        
Weighted average shares outstanding 143.5 150.9 143.5 151.4
Assumed conversion of preferred shares 12.1 12.1 12.1 12.1
Assumed conversion of restricted stock units 0.5 0.8 0.3 0.6
Assumed conversion of stock options 1.0   4.0   0.5   3.5  
Total diluted shares 157.1   167.8   156.4   167.6  
Adjusted EPS 0.53   1.20   0.62   2.26  

1 See Table 7 for details

2 The adjusted tax rate for the three and six months ended June 30, 2009 is 29% based on the forecasted adjusted tax rate for 2009.

3 Potentially dilutive shares are included in the adjusted earnings per share calculation when adjusted earnings are positive.

Table 7
 
Reconciliation of Other Charges and Other Adjustments
 
Other Charges:
  Three Months Ended   Six Months Ended  
June 30, June 30,
(in $ millions) 2009   2008 2009   2008
Employee termination benefits 5 4 29 11
Plant/office closures - - - 7
Ticona Kelsterbach plant relocation 3 3 6 5
Clear Lake insurance recoveries - - (6 ) -
Plumbing actions (2 ) - (3 ) -
Asset impairments -   -   1   -  
Total 6   7   27   23  
 
 
Other Adjustments: 1
Three Months Ended Six Months Ended Income
June 30, June 30, Statement
(in $ millions) 2009 2008 2009 2008 Classification
Ethylene pipeline exit costs - (2 ) - (2 ) Other income/expense, net
Business optimization 1 9 3 18 SG&A
Ticona Kelsterbach plant relocation 1 (2 ) 2 (4 ) Cost of sales
Plant closures 4 7 8 7 Cost of sales
Other2 (15 ) 5   (10 ) 4   Various
Total (9 ) 17   3   23  
 
Total other charges and other adjustments (3 ) 24   30   46  

1 These items are included in net earnings but not included in other charges.

2 June 30, 2009 includes a one-time adjustment to Equity in net earnings (loss) of affiliates of $19 million.

 
Table 8
 
Equity Affiliate Preliminary Results - Total - Unaudited
  Three Months Ended   Six Months Ended
(in $ millions) June 30, June 30,
  2009   2008 2009   2008
Net Sales
Ticona Affiliates1 267 364 439 717
Infraserv2 487 592 997   1,140
Total 754 956 1,436   1,857
 
Operating Profit
Ticona Affiliates 9 41 (10 ) 74
Infraserv 26 29 51   48
Total 35 70 41   122
 
Depreciation and Amortization
Ticona Affiliates 19 16 46 39
Infraserv 24 29 47   56
Total 43 45 93   95
 
Affiliate EBITDA3
Ticona Affiliates 28 57 36 113
Infraserv 50 58 98   104
Total 78 115 134   217
 
Net Income
Ticona Affiliates 7 22 (9 ) 42
Infraserv 16 27 35   25
Total 23 49 26   67
 
Net Debt
Ticona Affiliates 245 165 245 165
Infraserv 482 356 482   356
Total 727 521 727   521
 
 
Equity Affiliate Preliminary Results - Celanese Proportional Share - Unaudited4
Three Months Ended Six Months Ended
(in $ millions) June 30, June 30,
  2009 2008 2009 2008
Net Sales
Ticona Affiliates 123 167 203 330
Infraserv 155 191 318   367
Total 278 358 521   697
 
Operating Profit
Ticona Affiliates 4 19 (4 ) 34
Infraserv 8 9 16   15
Total 12 28 12   49
 
Depreciation and Amortization
Ticona Affiliates 9 7 21 17
Infraserv 8 10 15   19
Total 17 17 36   36
 
Affiliate EBITDA3
Ticona Affiliates 13 26 17 51
Infraserv 16 19 31   34
Total 29 45 48   85
 
Equity in net earnings of affiliates (as reported on the Income Statement)
Ticona Affiliates5 4 10 (4 ) 19
Infraserv 4 7 10   8
Total 8 17 6   27
 
 
Affiliate EBITDA in excess of Equity in net earnings of affiliates6
Ticona Affiliates 9 16 21 32
Infraserv 12 12 21   26
Total 21 28 42   58
 
Net Debt
Ticona Affiliates 111 76 111 76
Infraserv 152 113 152   113
Total 263 189 263   189

1 Ticona Affiliates includes Polyplastics (45% ownership), Korean Engineering Plastics (50%), Fortron Industries (50%), and Una SA (50%)

2 Infraserv includes Infraserv Entities valued as equity investments (Infraserv Höchst - 31% ownership, Infraserv Gendorf - 39% and Infraserv Knapsack - 27%)

3 Affiliate EBITDA is the sum of Operating Profit and Depreciation and Amortization, a non-U.S. GAAP measure

4 Calculated as the product of figures from the above table times Celanese ownership percentage

5 June 30,2009 excludes a one-time tax adjustment to Equity in net earnings (loss) of affiliates of $19 million.

6 Product of Celanese proportion of Affiliate EBITDA less Equity in net earnings of affiliates; not included in Celanese operating EBITDA

Analysen zu Celanese Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Celanese Corp. 69,06 -0,23% Celanese Corp.